×
Aurora Cannabis Receivables 2017-2024 | ACB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Aurora Cannabis receivables from 2017 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Aurora Cannabis Receivables 2017-2024 | ACB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Aurora Cannabis receivables from 2017 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$202.6B
Stryker (SYK)
$144.4B
Boston Scientific (BSX)
$130.4B
Medtronic (MDT)
$113.2B
EssilorLuxottica (ESLOY)
$112.1B
Lonza Group Ag (LZAGY)
$45.3B
Haleon (HLN)
$43B
GE HealthCare Technologies (GEHC)
$39B
ResMed (RMD)
$36.5B
Terumo (TRUMY)
$30.6B
Koninklijke Philips (PHG)
$24.9B
Zimmer Biomet Holdings (ZBH)
$21.8B
Insulet (PODD)
$19.3B
Baxter (BAX)
$17.5B
Smith & Nephew SNATS (SNN)
$10.8B
Bio-Rad Laboratories (BIO)
$10.2B
BellRing Brands (BRBR)
$9.2B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$5.8B
TG Therapeutics (TGTX)
$4.8B
Haemonetics (HAE)
$4.6B
ICU Medical (ICUI)
$4.4B
Prestige Consumer Healthcare (PBH)
$4B
Perrigo (PRGO)
$3.6B
Envista Holdings (NVST)
$3.6B
Neogen (NEOG)
$3.6B
Agios Pharmaceuticals (AGIO)
$3.4B
GN Store Nord (GNNDY)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.9B